| Application no. and date | 13740743.3 (espacenet) (Federated) (European Patent Register), 20130123 | | Patent/reg. no. and date | DK/EP 2806877, 20191009 | | Publication date | 20141203 | | Priority no. and date | US 201261589740 P, 20120123 | | EP pub. no. and date |
EP 2806877 20141203 | | Effective date | | | Applicant/owner | Sage Therapeutics, Inc., 55 Cambridge Parkway
Cambridge, MA 02142, US | | Applicant ref. no. | P24523DKEP | | Inventor | REDDY, Kiran, 215 First Street
Cambridge, MA 02142, US | | Representative | Patrade A/S, Ceresbyen 75, 8000 Århus C, DK | | Opponent | | | IPC Class | A61K 31/57 (2006.01) , A61K 47/69 (2017.01) , A61P 25/00 (2006.01) , A61P 25/08 (2006.01) | | Title | NEUROAKTIVE STEROIDFORMULERINGER OMFATTENDE ET KOMPLEKS AF ALLOPREGNANOLON OG SULFOBUTYLETHER BETA-CYCLODEKSTRIN | | Int. application no. | US2013022772 | | Int. publication no. | WO2013112605 | | Related patent (certificate) | | | Status | Ændret EP patent ikke valid i DK | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
